Status:
RECRUITING
Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions:
Lung Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
The goal of this observational study is to evaluate the efficacy and long-term clinical outcomes of early-stage lung cancer patients who have received surgery using the real-world data. The main quest...
Detailed Description
This observational study aims to comprehensively evaluate the effectiveness and long-term clinical outcomes of surgical interventions in early-stage lung cancer patients, utilizing real-world data. C...
Eligibility Criteria
Inclusion
- Aged between 18 and 85;
- Did not receive neoadjuvant therapy before surgery;
- No history of radiation therapy;
- Eastern Cooperative Oncology Group (ECOG) score is 0-1;
- Have complete clinically relevant information including imaging data;
- All patients underwent relevant preoperative examinations;
- Stage I lung cancer (International Association for the Study of Lung Cancer/The Union for International Cancer Control staging eighth edition);
Exclusion
- Have previously received chemotherapy, radiotherapy and other anti-tumor therapy;
- Data loss and error in medical records due to human/objective reasons.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2034
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT06483698
Start Date
March 1 2024
End Date
December 1 2034
Last Update
August 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shugeng Gao
Beijing, Beijing Municipality, China, 100020